(Q41112395)

26 September 2017

1 reference

title

Cellular drug efflux and reversal therapy of cancer (English)

1 reference

26 September 2017

P W Wigler

1

1 reference

26 September 2017

1 June 1996

1 reference

Journal of Bioenergetics and Biomembranes

26 September 2017

1 reference

26 September 2017

28

1 reference

26 September 2017

279-284

1 reference

26 September 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02110701

26 September 2017

0 references

cites work

Clinical trials of modulation of multidrug resistance. Pharmacokinetic and pharmacodynamic considerations

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02110701

Inhibition of the multidrug resistance efflux pump

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02110701

Cinchonine, a potent efflux inhibitor to circumvent anthracycline resistance in vivo

21 January 2018

1 reference

12 December 2020

Effect of duration of exposure to verapamil on vincristine activity against multidrug-resistant human leukemic cell lines.

1 reference

12 December 2020

Clinical trials of agents that reverse multidrug resistance. A literature review

1 reference

12 December 2020

Feasibility of using quinine, a potential multidrug resistance-reversing agent, in combination with mitoxantrone and cytarabine for the treatment of acute leukemia.

1 reference

12 December 2020

Using purified P-glycoprotein to understand multidrug resistance.

1 reference

12 December 2020

Systemic toxic effects associated with high-dose verapamil infusion and chemotherapy administration

1 reference

12 December 2020

Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells

1 reference

12 December 2020

Structural determinants of phenoxazine type compounds required to modulate the accumulation of vinblastine and vincristine in multidrug-resistant cell lines

1 reference

12 December 2020

Restoration of daunomycin retention in multidrug-resistant P388 cells by submicromolar concentrations of SDZ PSC 833, a nonimmunosuppressive cyclosporin derivative

1 reference

12 December 2020

Alteration of etoposide pharmacokinetics and pharmacodynamics by cyclosporine in a phase I trial to modulate multidrug resistance

1 reference

12 December 2020

Biochemistry of multidrug resistance mediated by the multidrug transporter

1 reference

12 December 2020

Comparative effects of quinine and cinchonine in reversing multidrug resistance on human leukemic cell line K562/ADM.

1 reference

12 December 2020

Reversal of multidrug resistance by lipophilic drugs.

1 reference

12 December 2020

Kinetics of daunorubicin transport by P-glycoprotein of intact cancer cells

1 reference

12 December 2020

Anthracycline resistance in P388 murine leukemia and its circumvention by calcium antagonists

1 reference

12 December 2020

Reversal agent inhibition of the multidrug resistance pump in human leukemic lymphoblasts.

1 reference

12 December 2020

Rejection criteria for the asymmetric carrier and their application to glucose transport in the human red blood cell

1 reference

12 December 2020

Characterization of multidrug resistance by fluorescent dyes.

1 reference

12 December 2020

P-glycoprotein-mediated efflux of hydroxyrubicin, a neutral anthracycline derivative, in resistant K562 cells

1 reference

12 December 2020

In vitro and in vivo modulation of multi-drug resistance with amiodarone

1 reference

12 December 2020

Effects of verapamil enantiomers and major metabolites on the cytotoxicity of vincristine and daunomycin in human lymphoma cell lines

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02110701

1 reference

26 September 2017

1 reference

PubMed ID

8807402